Form 497VPSUB PACIFIC SELECT EXEC SEPA
Supplement
dated September 25, 2026, to the Statutory Prospectus dated May 1, 2013 for the following
variable universal life policies:
| Issued by Pacific Life Insurance Company | Issued by Pacific Life & Annuity Company |
| Pacific Select Accumulator | Pacific Estate Preserver-NY |
| Pacific Select Choice | Pacific Select Exec II-NY |
| Pacific Select Estate Maximizer | Pacific Select Exec III-NY |
| Pacific Select Estate Preserver | Pacific Select Exec IV-NY |
| M's Versatile Product - Survivorship | |
| Pacific Select Estate Preserver II | |
| Pacific Select Estate Preserver III | |
| Pacific Select Estate Preserver IV | |
| Pacific Select Estate Preserver V |
The purpose of this supplement is to announce various underlying fund changes. This supplement must be preceded or accompanied by the Statutory Prospectus, for your Policy, as supplemented. Capitalized terms used in this supplement are defined in your Prospectus unless otherwise defined herein. "We'', "us'', or "our" refer to Pacific Life Insurance Company, as applicable; "you" or "your" refer to the Policy Owner. You can obtain a copy of the current Prospectus by contacting us at (800) 800-7681, or online at PacificLife.com/Prospectuses. Please retain this supplement for future reference.
The purpose of this supplement is to notify Policy Owners of an upcoming underlying fund substitution (the “Substitution”). On or about November 1, 2026 (the “Substitution Date”), in accordance with standards of the U.S. Securities and Exchange Commission, shares of the following “Current Portfolio” will be substituted for shares of the following “Replacement Portfolio,” as set forth in the table below:
| Current Portfolio | Replacement Portfolio |
| LVIP American Century Mid Cap Value Fund Service Class | Invesco V.I. American Value Fund Series II |
After the close of the New York Stock Exchange (typically 4:00 p.m. EST on October 30, 2026), all Accumulated Value in any Subaccount investing in a Current Portfolio will automatically be reallocated to the Subaccount investing in the corresponding Replacement Portfolio. After the Substitution Date, no new allocations may be made to the Subaccount investing in the Current Portfolio, and such Subaccount will no longer be available for investment under the Policy.
Your Accumulated Value immediately prior to the Substitution will equal your Accumulated Value immediately after the Substitution. There will be no tax consequences for you as a result of the Substitution. The Substitution will be performed at no cost to you. The Policy’s fees and charges will not increase as a result of the Substitution. Your rights and our obligations under the Policy will not be altered in any way.
You may reallocate Accumulated Value in the Subaccount investing in the Current Portfolio for thirty (30) calendar days prior to the Substitution Date, or from the Subaccount investing in the Replacement Portfolio within thirty (30) calendar days after the Substitution Date. Neither the Substitution, nor any transfer of Accumulated Value as described above, will count against any limit on free transfers that you are permitted to make each year. All other transfers are subject to limitations as described in your product Prospectus. Any standing instructions or investment restrictions applicable to your Policy that include a Subaccount investing in a Current Portfolio will be automatically updated to include the Subaccount investing in the corresponding Replacement Portfolio.
Please work with your financial professional to determine if your existing allocation instructions should be changed before or after the Substitution Date. You may submit a transfer request to us electronically by signing into your account at www.PacificLife.com, by telephone at (800) 347-7787, or by using any other means described in the product Prospectus. Please see Timing of Payments, Forms and Requests in the product Prospectus for details.
Copies of the Replacement Portfolio’s prospectus accompany this Supplement. You should read them carefully.
Any references to the Current Portfolio are deleted from the product Prospectus after the Substitution Date.
| Form No. | 15-53370-00 | |
| 85-53371-00 | ||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TNS to Tackle Cross-Channel Fraud and Customer Trust in Two Sessions at CFCA Fall Educational 2026
- Flexsteel Industries, Inc. to Participate in the Lytham Partners Fall 2026 Investor Conference
- Crescent Biopharma Announces Grants of Inducement Awards
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share